Search for: "Cliffs Sales Company" Results 1 - 20 of 178
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Aug 2012, 7:00 am by Gene Quinn
The realities presented by a patent cliff often drive giant pharmaceutical companies to acquire smaller pharmaceutical companies and research and development companies to help stack their own pipeline with potential blockbuster drugs to address the enormous drop in revenues that is the hallmark of a patent cliff. [read post]
23 Aug 2012, 7:00 am by Gene Quinn
The realities presented by a patent cliff often drive giant pharmaceutical companies to acquire smaller pharmaceutical companies and research and development companies to help stack their own pipeline with potential blockbuster drugs to address the enormous drop in revenues that is the hallmark of a patent cliff. [read post]
15 Sep 2015, 8:40 am by Law Offices of Jeffrey S. Glassman
In order to increase sales, which have become somewhat stagnant after the market reached what is known as the patent cliff, BMS increased direct marketing to consumers and tried to expand to other markets in Asia. [read post]
1 Jun 2012, 4:25 am by Jeff Marshall
 The Fiscal Cliff: Witching Hour is set for January 1, 2013As Federal Reserve Chairman Ben Bernanke has noted, at the end of 2012 “there’s going to be a massive fiscal cliff of large spending cuts and tax increases. [read post]
16 Nov 2010, 2:43 pm by FDABlog HPM
”  The “180-day exclusivity cliff” tracks the “patent cliff” brand-name companies are expected to face as many blockbuster drugs come off patent between 2011 and 2014. [read post]
14 Jun 2012, 11:55 am by Stephen Jenei
With four days left until BIO 2012 in Boston, EvaluatePharma’s World Preview 2018 warns of excessive R&D spending, but patent cliff may “liberate” drug companies. [read post]
23 Jun 2008, 5:45 pm
While merged companies are able to up their revenue growth in the first year, after that, revenue growth seems to fall off a cliff. [read post]
14 Nov 2021, 4:58 am by Dan Harris
Is your company “too” dependent on China for its products or its sales? [read post]
6 Feb 2014, 5:00 am by Doug Cornelius
They thought the company was for sale and thought they could profit from the sale. [read post]
15 Jul 2013, 11:05 am by Lawrence B. Ebert
The drugs accounted for a combined 20% of 2012 revenues.As to AstraZeneca:Why the company did it: Part of a comeback strategy by CEO Pascal Soriot following years of clinical setbacks involving drug candidates the company hoped would make up for sales revenues to be lost from “patent cliff” expirations through 2014, when the company will lose U.S. patent protection for two of its biggest selling drugs—its proton pump inhibitor Nexium,… [read post]
1 Jan 2014, 5:54 am by Rich Vetstein
Last year, Congress rushed to extend the law during negotiations about the fiscal cliff but only through the end of 2013. [read post]
7 Aug 2008, 4:43 am
As published today on The Wall Street Journal's Health blog, EvaluatePharma predicts the following changes in pharma company rankings based on prescription and over-the-counter sales between 2007 and... [read post]
19 Apr 2015, 4:01 pm
It is estimated that in 2015 $47.5 billion of lost sales will affect the industry overall. [read post]
26 Dec 2012, 3:00 pm by Craig
  When a mortgage company agrees to accepts a lesser amount than what is due on the mortgage, then the amount of savings can be taxed as if it were ordinary income. [read post]
11 May 2015, 11:29 pm by Florian Mueller
So let's build a comprehensive list of privateering transactions.AppleDigitude Innovations (sale of patents via Cliff Island LLC, a shell company)EricssonOptis Wireless (link points to patent application filed by Ericsson and taken over by Optis)Unwired PlanetHuaweiInventergyNokiaAcaciaIntellectual VenturesInventergyMobileMedia Ideas (with Sony)Mosaid (now Conversant)PendrellVringoWiLAN (patent acquisition agreement mentioned in connection with license… [read post]
7 Jan 2013, 11:38 am by LindaMBeale
  And those companies happen to be companies that HAVE to do considerable research to stay competitive. [read post]
27 Feb 2007, 2:58 am
Naccio contends that he believed that the company's finances and prospects were fine, and that his stock sales were simply a diversification strategy that he was pursuing at the behest of his investment advisors. [read post]
22 Sep 2011, 12:31 pm by Andrew Ramonas
The company did not engage in lobbying during the first half of this year. [read post]